Venture Life Share Discussion Threads

[big7ime] 19/7/2017 10:05

My charting is getting much better, last wk identified 2 buy triggers iqe 75, now 85.
AMER 17, now 19.38
Technical term I think is support ;)

[panic investor] 19/7/2017 10:01

FEVR and GAW both ahead trading wise report Tuesday

[panic investor] 19/7/2017 10:00

Traded that sold around an hour ago :-) .... hopefully RST brings home the bacon tomorrow too !

[big7ime] 19/7/2017 09:59

TSTL profit up 20%, share price up over 100% in 12mths. Another that emphasises my point unless I'm missing something, do enlighten me. They are obviously going to pass the divi from that last statement too which could be messy come results

[apad] 19/7/2017 09:12

Now's the time, in my view. Placing at 222p.
apad

[saj3] 19/7/2017 08:51

Anyone still in BOO looking to take a position

[apad] 19/7/2017 08:43

I did, pete.

What's Not To Like

Apologies for making it look like an epic code.

Bought a few HLMA ahead of a possible trading statement at tomorrow's agm.
Using IAB oooerrrr misus.

Might try red's technique of reducing the cost again, if it rises.

apad

[petersinthemarket] 19/7/2017 08:29

> did you mean TSTL for tristel? pete

[lauders] 19/7/2017 08:04

Your garden should be rather lush without my help then Apad! If I could I would. Don't quite have that power. If I had I would also make all my shares go up only and fix all the wrongs in the world ;-)

[someuwin] 19/7/2017 08:01

19 July 2017

Venture Life Group plc

("Venture Life" or "the Group")

New long term distribution partner for UltraDEX and patent update

Venture Life (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the ageing population, announces the signing of a new long term distribution agreement for its UltraDEX range across four new markets. In addition to this, the European Patent Office has granted an EU patent over the UltraDEX sensitive range, and a patent application is now pending on the new MycoClear product for onychomycosis.

UltraDEX

Venture Life announces it has entered into a partnership with Karo Pharma AB (Sweden), a publicly listed company for its UltraDEX range of products. This long term distribution agreement covers Norway, Sweden, Denmark and Finland. This marks the start of a collaboration between both parties as Venture Life continues to grow the brand internationally and build on the success the Group is seeing in the UK market with the UltraDEX brand.

Commenting, Peter Blom, CEO of Karo Pharma AB said: "We are delighted to partner with Venture Life and we look forward to sharing the success they have seen in the UK market, in the Nordic region in the coming years."

The Company also announces that it has received notification from the European Patent Office that it has been granted a patent for the UltraDEX Sensitive range across Europe. The UltraDEX Sensitive product is specifically designed for users who experience increased tooth sensitivity. This patent adds to the existing portfolio of patents granted for this product covering the USA, Japan, Mexico, Indonesia, Australia and New Zealand.

Commenting, Chief Executive Officer, Jerry Randall, said: "Karo Pharma AB becomes our latest international partner for the UltraDEX brand and we are delighted to partner with such a well- established public company in four new markets. The extension of our patent portfolio into Europe also strengthens the brand's value and opportunity for further international partner opportunities."

MycoClear

Venture Life also announces that it has filed a patent with the Italian Patent Office on its new MycoClear product for Onychomycosis (fungal nail infection). MycoClear has been developed to deal with both the aesthetic issue of the condition and the underlying infection, which causes discoloured, misshapen nails on both the hands and feet. The European market alone for Onychomycosis products is EUR85m and this product brings innovative design to an area where current products often have low levels of efficacy. As previously announced, the product is already approved as a Class IIa medical device and since that approval, the Company has begun a clinical programme to strengthen the package of data around this product. Early indications from potential partners show a high level of interest in MycoClear and the Company expects to see partnering deals from this product in the next twelve months.

Other International Developments

The Company has received registration approval in Jordan for Procto-eze cream and cleanser together with the new Benecol 'once a day' liquid sachet. The commercial launch for these products is expected late H2 2017/early H1 2018. Procto-eze is a highly absorptive light cleanser and cream for the treatment of anal irritation and Benecol(R)(1) 'once a day' liquid sachet has been developed for lowering LDL cholesterol. The Company has also signed a further two long term distribution agreements in Israel for Procto-eze and Vonalei with Taro Pharmaceutical Industries Ltd.

________________

(1) Benecol is a registered trademark of Raisio Nutrition Ltd

Commenting, Chief Executive Officer, Jerry Randall, said: "The Group made good progress in the first half of the year and I'm pleased to report on continuing partnership deals, patent and product approval activity. I am confident we have the right team in place to unlock the full potential of UltraDEX both domestically and internationally and also promote our other key products."

[apad] 19/7/2017 07:50

Google feed has repaired itself!
apad

[apad] 19/7/2017 07:19

Tracsis major rail contract at long last! Won't impact current year. Still no yoodle news. No longer own.

Tristel (WNTL):

"For the year ended 30 June 2017 Tristel will record turnover in excess of £20 million (2016: £17.1 million) and pre-tax profit (before share-based payments) of at least £4 million (2016: £3.3 million). Both turnover and pre-tax profit are ahead of market expectations. In the second half, revenue from overseas markets contributed 50% of the Group total compared to 43% in the first half, and for the full year overseas revenue represented 47% of Group revenue - a record level. Tristel has continued to generate significant levels of cash and at 30 June 2017 cash balances were £5.1 million (30 June 2016: £5.7 million). The Company has no debt."

apad

[apad] 19/7/2017 07:07

Google feed gone to rats again!

apad

[apad] 19/7/2017 07:02

QTX interim in a week. Class act. Instructive comparison with TRAK continues!

"We have made good progress in all fleet markets. New installations of tracking systems grew by 44% to 14,300 vehicles and we ended the period with more than 10,000 fleet customers and over 97,000 active vehicle subscriptions. New UK installations grew by 44% to 10,450, increasing the subscription base to 78,000 vehicles; in France they rose by 30% to 1760 vehicles, reaching a closing base of over 11,400; and in the USA they increased by 60% to 2,090, lifting the base to 7,700 vehicles."

"Following the decision taken last year to concentrate management time on our core fleet business and to focus on only those insurance opportunities which deliver adequate returns, insurance installations decreased by 35% compared to 2016. We are pleased with progress made in this transition and Group gross margin for the period is expected to have been broadly in line with last year."

"We will continue to invest in our fleet business in the second half and only add back insurance volume where our quality of service and product innovation mean that we can command attractive margins."

apad

[apad] 19/7/2017 06:54

"not a significant holding"
Delighted to hear it, L.
Pretty boy's lifestyle company.
apad
ps
Please send some tropical rain - I'm having to do well on the market to pay for watering the garden.

[lauders] 19/7/2017 01:54

Apad - Had to look at the share price to see what you were talking about! Oh dear :-( I think a vet will still be needed, have to try and get the heart to start pumping again! Luckily not a significant holding, but just wondering whether I should top-up? (tongue in cheek!).

DOTD looked OK to me. Perhaps there will be a delayed positive share price reaction? Still not holding but if there are any BTFD opportunities that may change. Missed the BVXP opportunity the other day damn!

Think I am on the same timing as you. Didn't pick-up on the Thailand link and I am typing from Thailand!

PS - Perhaps the puppy will survive the vet and do a FENR one of these days? ;-)

[hydrus] 18/7/2017 22:46

AMZN making new highs tonight. Bell weather for wider market or just an incredible company?

[apad] 18/7/2017 20:48

I haven't got to where I am without being slow!
apad

[janeann] 18/7/2017 20:24

His point was frocks! and boys. I saw his inference; bit slow there!

[apad] 18/7/2017 20:16

Errrr. Yeah.
Daughter worked in Indonesia, Malaysia, Singapore.
Thailand - lots of guns.
Your point is?
apad

[panic investor] 18/7/2017 20:13

You never know apad ! Ever been to Thailand :-)

[apad] 18/7/2017 20:10

Dollar and Euro.
I don't think I understand what is going on.
apad